Status:

COMPLETED

Immuno-regulatory Profiling of T Cells in GVHD Treated With Extracorporeal Photopheresis

Lead Sponsor:

Henry Ford Health System

Conditions:

GVHD

Eligibility:

All Genders

18-75 years

Brief Summary

Extracorporeal Photopheresis (ECP) has been used as one of the treatments for graft versus host disease (GVHD). Responses were observed in skin, liver, GI tract, mouth, eye and lung. ECP does not caus...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients who are recipients of allogeneic stem cell grafts.
  • Patients with the diagnosis of GVHD according to established criteria and physician decides to treat using ECP
  • Patient must have 100% chimerism with the donor
  • No recent donor lymphocyte infusion.
  • Patients must be able to sustain a platelet count and a hematocrit \> 20,000/mL and \> 27% respectively, with or without transfusions.
  • The absolute WBC must be \>1500/mL
  • Patient must be willing to comply with all study procedures.
  • Exclusion criteria:
  • Patients who are unable to tolerate the volume shifts associated with ECP treatment due to the presence of any of the following conditions: uncompensated congestive heart failure, pulmonary edema, severe asthma or chronic obstructive pulmonary disease, hepatorenal syndrome.
  • Active bleeding.
  • International normalized ration (INR) \>2.
  • Patients with known hypersensitivity or allergy to psoralen.
  • Patients with known hypersensitivity or allergy to both citrate and heparin.
  • Patients with co-existing photosensitive disease (e.g. porphyria, systemic lupus erythematosus, albinism) or coagulation disorders.
  • Active, uncontrolled infection

Exclusion

    Key Trial Info

    Start Date :

    August 26 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 30 2023

    Estimated Enrollment :

    6 Patients enrolled

    Trial Details

    Trial ID

    NCT03851601

    Start Date

    August 26 2014

    End Date

    June 30 2023

    Last Update

    October 26 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Henry Ford Hospital

    Detroit, Michigan, United States, 48202